Key Takeaways
- • McGuireWoods partners Bart Walker and LauraLee Lawley, along with associate Natalie Galdos, published guidance in Dentistry Today's April 2023 edition addressing critical factors for dental and physician practices evaluating private equity partnerships or sales.
- • The article identifies valuation disparity as a primary market challenge, with the authors noting "a growing gulf between buyer and seller expectations of overall valuation and purchase price" in healthcare provider transactions.
- • Key deal considerations covered include valuation methodologies, deal structure optimization, purchase agreement terms, employment agreement provisions, fee structures, compensation models, and risk allocation frameworks.
- • The guidance addresses emerging regulatory headwinds, specifically a proposed Federal Trade Commission rule targeting noncompete agreements between employers and workers—a material consideration for practices negotiating PE transactions.
- • Private equity penetration in dentistry has accelerated materially, with PE-affiliated dentists increasing from 6.6% in 2015 to 12.8% in 2021, reflecting sustained consolidation pressure in the sector.
Summary
McGuireWoods, a major healthcare-focused law firm, published substantive guidance on private equity transactions in dental and physician practices through its Healthcare Department specialists. The article, authored by Charlotte-based partners Bart Walker and LauraLee Lawley alongside associate Natalie Galdos, addresses a critical juncture in healthcare provider M&A as private equity capital continues to consolidate the dental and medical services sectors.
The authors articulate a central tension in current market dynamics: significant valuation divergence between buyers and sellers. As healthcare valuations experience material shifts, institutional buyers and practice owners remain misaligned on deal economics. This valuation gap carries strategic implications for both PE sponsors seeking portfolio expansion and practitioners evaluating exit timing.
The published guidance provides practitioners with a structured framework for evaluating PE partnerships across eight core dimensions: valuation methodologies, deal structure alternatives, purchase agreement protections, employment agreement terms, fee arrangements, compensation model selection, risk allocation mechanisms, and compliance considerations. The framework addresses both deal negotiation and post-acquisition integration considerations critical to transaction success.
Regulatory environment represents an increasingly material variable in PE healthcare transactions. The proposed FTC rule restricting noncompete agreements creates structural uncertainty around talent retention and operational continuity—traditional value drivers in dental and physician practice roll-ups. This regulatory development effectively reshapes the risk-reward calculus for both buyers and sellers, requiring explicit treatment in transaction documentation.
The article reflects broader market realities: PE affiliation among dentists has nearly doubled over a six-year period, rising from 6.6% of practitioners in 2015 to 12.8% by 2021. This trajectory suggests continued consolidation momentum, positioning legal guidance on transaction mechanics as increasingly essential for practice stakeholders navigating partnership decisions with institutional capital.
The authors articulate a central tension in current market dynamics: significant valuation divergence between buyers and sellers. As healthcare valuations experience material shifts, institutional buyers and practice owners remain misaligned on deal economics. This valuation gap carries strategic implications for both PE sponsors seeking portfolio expansion and practitioners evaluating exit timing.
The published guidance provides practitioners with a structured framework for evaluating PE partnerships across eight core dimensions: valuation methodologies, deal structure alternatives, purchase agreement protections, employment agreement terms, fee arrangements, compensation model selection, risk allocation mechanisms, and compliance considerations. The framework addresses both deal negotiation and post-acquisition integration considerations critical to transaction success.
Regulatory environment represents an increasingly material variable in PE healthcare transactions. The proposed FTC rule restricting noncompete agreements creates structural uncertainty around talent retention and operational continuity—traditional value drivers in dental and physician practice roll-ups. This regulatory development effectively reshapes the risk-reward calculus for both buyers and sellers, requiring explicit treatment in transaction documentation.
The article reflects broader market realities: PE affiliation among dentists has nearly doubled over a six-year period, rising from 6.6% of practitioners in 2015 to 12.8% by 2021. This trajectory suggests continued consolidation momentum, positioning legal guidance on transaction mechanics as increasingly essential for practice stakeholders navigating partnership decisions with institutional capital.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.